Walmark - From EBITDA to Net Profit

Net Profit, EBIT & EBITDA (CZK mil)
Pharmaceutical | Czech Republic | March 06, 2018
Excel Sheet

Walmark made a net profit of CZK 41.8 mil under revenues of CZK 2,294 mil in 2014, up 585% and 18.2%, respectively, when compared to the last year. This translates into a net margin of 1.82%.

Historically, the firm’s net profit reached an all time high of CZK 214 mil in 2011 and an all time low of CZK -164 mil in 2008. Since 2009, the firm's net profit has increased -60.6% or -17.0% a year on average.

On the operating level, EBITDA reached CZK 215 mil, up 70.2% when compared to the previous year. Over the last five years, company's EBITDA has grown -6.36% a year on average.

As far as Walmark's peers are concerned, Roche Czech Republic posted net and EBITDA margin of 2.17% and 6.07%, respectively in 2014, Bayer Czech Republic generated margins of 2.64% and 3.53% and Amgen Czech Republic's profit margin reached 6.36% on the net and 8.55% on the EBITDA level in 2014.

You can see all the company’s data at Walmark Profile, or you can download a report on the company in the report section.